Comment

Comment by Dr. Krishna Kumari Challa 12 hours ago

The rising number of parents refusing the intervention has added a new layer of complexity to diagnosing sick infants in the ED, where the most common cause of bleeding is trauma, such as a fall.

When evaluating infants who did not receive vitamin K injections, "clinicians may need to consider serious bleeding complications when evaluating otherwise nonspecific symptoms such as lethargy, vomiting, seizures, or pauses in breathing."
Parents refuse the shot for a wide range of reasons. One 2019 qualitative study found the refusal was often driven by a broad aversion to anything perceived as foreign or interventional at birth.

Increasingly, refusals are driven by misinformation circulating on social media that often conflates the shot with vaccines simply because it is an injection administered at birth. "But it's not a vaccine—it's a vitamin supplement."
Oral vitamin K—sometimes offered if parents turn down the injection—is not a reliable alternative because absorption through a newborn's gut is inconsistent, and repeat dosing would be required throughout the newborn period, says Howard.

Other reasons parents object to the birth dose:

Fear of side effects: Parents have encountered unfounded claims online about dangerous complications. In reality, decades of use support the shot's safety profile.
The cancer myth: A small study from the 1980s suggested a possible link between the shot and childhood cancer, but subsequent larger, more rigorous studies have not confirmed that association. "We have strong evidence to support that it does not increase an individual's cancer risk," Howard says.
"Breast milk is enough": Some parents mistakenly believe breastfeeding provides sufficient vitamin K—but it does not, says Thorne-Lyman. Unlike vitamin D, which can be meaningfully enriched in breast milk if the mother is sufficiently supplemented, "even if the woman is eating a good diet that's rich in vitamin K sources, there is still a possibility that their child is going to be deficient," he explains. Formula-fed infants may have a somewhat lower risk because formula contains added vitamin K, but the injection is still recommended for all newborns.
Delayed cord clamping: Some families believe that leaving the umbilical cord attached longer will transfer enough vitamin K from the placenta. "Placental transfer of vitamin K is very low, including through the cord blood, so delayed cord clamping does not provide sufficient vitamin K to prevent VKDB," Howard says.
A broader dynamic is also at play: Because VKDB became so rare after the shot was introduced, many parents have no frame of reference for how serious it can be. Because the underlying disease has become invisible, it produces a level of complacency.
Parents, unfortunately, are turning to social media rather than being able to sit down with their pediatrician.
We know now from decades of evidence and use that it is safe, effective, and necessary to prevent vitamin K deficiency bleeding, which can have deadly, or if not deadly, lifelong consequences for an infant.

https://hub.jhu.edu/2026/05/15/what-parents-need-to-know-newborn-vi....

Comment by Dr. Krishna Kumari Challa 12 hours ago

The newborn vitamin K shot: What every parent needs to know

The vitamin K shot is one of the oldest, safest, and most effective preventive interventions in newborn medicine.
The American Academy of Pediatrics—which first endorsed the intervention in 1961—recommends the shot be administered within six hours of birth. But amid a flood of misinformation online, more parents are refusing the shot for their newborns, sometimes with devastating consequences—highlighting the need for better communication about its benefits and the risks of forgoing it.
A single intramuscular vitamin K injection at birth effectively prevents vitamin K deficiency bleeding (VKDB), a potentially fatal condition in newborns who have naturally low vitamin K levels. Without the injection, the risk of VKDB increases up to 81-fold, with consequences including irreversible brain damage or death. Oral alternatives are unreliable, and breast milk does not provide sufficient vitamin K. The injection is safe, with no proven link to cancer or serious side effects.
No parent wants their child to bleed to death. No parent wants their child to have hemorrhaging in their brain.
Vitamin K is essential for blood clotting, but newborns are born with very low levels of the nutrient, making them vulnerable to vitamin K deficiency bleeding, or VKDB—a condition that can cause internal bleeding in the brain, intestines, and other vital organs.

The single vitamin K injection—typically 0.5 mg to 1.0 mg given just after birth— prevents VKDB during the critical first months of life while the baby is building up their own vitamin K stores and before they start eating solid foods around 4–6 months old.

Without the vitamin K shot, the risk of bleeding is up to 81 times higher, with incidents occurring in 1 in 14,000 to 25,000 babies.

While most adults naturally maintain healthy vitamin K levels produced by bacteria in the gut and a balanced diet, the nutrient "does not cross the placenta easily."
Breast milk does not provide sufficient amounts after the birth.
The consequences of VKDB can be swift and devastating—and there's no reliable way to measure a baby's risk.
And the only sign that something is wrong is sudden, catastrophic bleeding, when the bleeding is already severe and difficult to reverse.
Brain bleeds are among the most serious outcomes. Depending on where blood accumulates and how quickly it is detected, consequences range from neurological impairment to death. "If [the hemorrhage] is pushing against the brainstem, which regulates a baby's breathing and heart rate, and it's not detected quickly enough, that has devastating consequences.
After bleeding begins, treatment options are limited. Vitamin K can be administered as a last resort to help stop active bleeding, but damage already done to the brain may be permanent.
Part 1

Comment by Dr. Krishna Kumari Challa 12 hours ago

Soil also suffers from heat waves: Organic waste boosts its tolerance to 50°C

Adaptability has its limits.

When the temperature exceeds 40 degrees, just as human health suffers, the microorganisms that inhabit the soil—and from there provide a multitude of ecosystem services, such as carbon sequestration and plant nutrition—concentrate more on survival than continuing their work.
A study conducted by researchers has determined the temperature limit that soil in various regions can reach before it begins to degrade. The study also provides insights into what we can do to help the soil.

Soil microbial activity and phosphorus availability decline sharply above 40°C, with near-total functional shutdown at 50°C, threatening soil health under recurrent heat waves. Incorporating organic amendments, particularly olive pomace, significantly enhances soil resistance and phosphorus retention at high temperatures, supporting soil resilience and ecosystem services amid climate change.

Above 40 degrees, microorganisms' ability to capture carbon diminishes, and it practically "shuts down" at 50 degrees.
The higher the temperature they endure, the lower the soil's phosphorus reserve becomes, which is virtually non-existent when exposed to temperatures above 40 degrees.
To address this issue, the research team has explored ways to mitigate the damage caused by high temperatures, which they aim to counteract through the use of organic additives that enhance soil resistance.

Sana Boubehziz et al, Soil Preservation in Warming Climate: Organic Amendments Enhance Microbial Carbon Use Efficiency in Mediterranean Soils, European Journal of Soil Science (2026). DOI: 10.1111/ejss.70323

Comment by Dr. Krishna Kumari Challa 12 hours ago

Keeping bacteria contained with a stiffer, tougher scaffold
The researchers involved in the new study identified two main aspects of existing hydrogel scaffolds that needed improvement. They wrote, "We hypothesized that fulfilling two key criteria for a material enables robust and durable containment of therapeutic bacteria: (i) resistance to the internal forces generated by proliferating bacteria and (ii) mechanical toughness sufficient to withstand deformation from surrounding tissues."

And so, the team engineered an implantable polyvinyl alcohol (PVA) hydrogel with optimized stiffness and toughness to keep expanding colonies from breaking through and to resist breakage under body movement. They then embedded engineered E. coli bacteria in protective microgels within it.

The team then tested out the new scaffold in various situations. They allowed the encapsulated bacteria to sit in a nutrient broth in the lab for six months, checking in on it frequently to see if any bacteria leaked out. But the scaffold held the bacteria for the entire six-month period.

They also evaluated fatigue resistance using cyclic crack growth testing, which tests how fast a flaw grows in a material under repeated loading. The PVA material showed a high fatigue threshold that indicated a 10-fold improvement over previous agarose-based materials. The new scaffold material also outperformed agarose in mechanical robustness testing and showed that the bacteria remained inside and functional under stress.
The new ILM material was then tested out as a local drug depot in a mouse model. The mice were implanted with a pin containing the ILM and then infected with a bacteria called Pseudomonas aeruginosa, which is common in implant surgeries and known for having an inherent resistance to many common classes of antibiotics. The bacteria in the scaffold were engineered to detect P. aeruginosa and release a drug to treat the infection.

The mice implanted with the new ILM material and engineered bacteria showed significantly reduced infection, compared to controls. Engineered bacteria inside the ILM were able to successfully detect infection signals and release the antimicrobial proteins to treat the infections in mice.

The team also performed testing on cancer cells in the lab, which showed successful drug delivery using the new materials. They write, "To evaluate platform versatility beyond antimicrobial therapy, we tested ILMs in a cancer-relevant context. Conditioned media from ILMs encapsulating Escherichia coli ClearColi (Ecc) engineered to express an inducible pore-forming toxin significantly reduced viability of CT26 cancer cells compared with GFP controls."

These results represent a big step in safer microbe-based drug delivery, although long-term safety and immune responses in humans still need to be studied. Further studies will also be helpful for determining potential effects or efficacy of chronic use and broader disease applications.

Tetsuhiro Harimoto et al, Implantable living materials autonomously deliver therapeutics using contained engineered bacteria, Science (2026). DOI: 10.1126/science.aec2071

Part 2

**

Comment by Dr. Krishna Kumari Challa 12 hours ago

Implantable bacteria can now be safely contained, clearing a major hurdle for fighting infection and cancer

Researchers have long known that bacteria could potentially be used to deliver therapeutic drugs inside the human body. However, safely and successfully carrying out such a feat in humans has been a challenge. But now, researchers  have made another step forward toward the goal of using microbes as medicine. Their recent study, published in Science, details a novel method for containing engineered bacteria to keep them from infecting their host while still successfully delivering potentially life-saving medications.

Researchers have had success in engineering implantable bacteria that can sense infections and then release medications to kill other bacteria or cancer cells. These engineered bacteria must still be contained, however, to prevent dissemination and toxicity.
To do this, attempts have been made using hydrogels to encapsulate the engineered bacteria, but these often failed to prevent escape over time due to increasing pressure from expanding bacterial colonies or under physical stress from the body. Genetic containment strategies have also been attempted, but often fail due to evolutionary changes in the bacteria over time.

Yet, the idea of bacteria as living therapeutics is still attractive to scientists because of their ability to colonize a wide range of physiological environments, such as mucosa, infected sites, skin, inflamed tissues and tumors, and the ability to deliver therapeutics in response to specific biological signals, as opposed to waiting until symptoms become noticeable in a compromised person. Still, a long-term, biocompatible solution that keeps bacteria confined while allowing them to function as drug factories is crucial for these implantable living materials (ILM) to provide reliable, safe therapies.

Part 1

Comment by Dr. Krishna Kumari Challa 14 hours ago

How the brain recombines past knowledge for flexible planning

When facing new situations or problems, humans typically rely on knowledge they acquired in the past. Specifically, neuroscience studies suggest that the brain reorganizes past experiences and previously acquired knowledge, creating mental frameworks that can help humans to solve the problems they are facing. The recombination of past knowledge into new mental structures also allows humans to flexibly plan future actions in changing environments. Past studies suggest that two key brain regions contribute to this process, the hippocampus and the medial prefrontal cortex (mPFC).

The hippocampus is a brain structure that plays a key role in the formation of memories and spatial navigation. The mPFC, on the other hand, is known to support decision-making, planning, reasoning and the integration of information.

Researchers  recently set out to investigate how the hippocampus and mPFC work together to combine past knowledge into new configurations. Their findings, published in Nature Neuroscience, suggest that this process is supported by brief bursts of high-frequency neural activity in the hippocampus, called hippocampal ripples, and the replay (i.e., re-activation) of past experiences in the brain.

The human brain excels at solving novel problems by flexibly recombining a limited set of familiar elements, often through the internal planning of sequences that assemble these elements into new configurations.

The researchers  analyzed brain activity recordings collected by the electrodes in the participants' brains during the experiment. This allowed them to understand how brain activity changed while the participants were combining past knowledge to complete the task at hand.

The brain activity patterns observed by the researchers suggest that the hippocampus and mPFC closely coordinate to recombine familiar pieces of information into new mental structures. Short bursts of brain activity (i.e., ripples) in the hippocampus appear to help the brain to reorganize stored memories.

During these ripple events, the brain appears to rapidly replay sequences of information, reorganizing familiar building blocks into new combinations that are useful for solving the problem/task at hand. Concurrently, the mPFC appears to update its activity patterns to represent the newly identified solution to a problem.

Hippocampal ripples shift mPFC representations toward the inferred relational configuration, facilitated by replay that reorganizes building blocks into candidate sequences," wrote the authors. "Replay is strongest during ripple periods, closely coordinates with mPFC activity and is predictive of efficient inferential behavior. Together, hippocampal ripples and replay emerge as a key mechanism for dynamically updating cortical representations online to support planning and inference."

This recent study offers new insight into how the human brain flexibly combines past knowledge to creatively tackle new tasks or problems.

Li He et al, Human hippocampal ripples coordinate planning sequences and compositional representations in neocortex, Nature Neuroscience (2026). DOI: 10.1038/s41593-026-02291-3

Comment by Dr. Krishna Kumari Challa 14 hours ago

Physicists created hybrid light-matter particles that interact strongly enough to compute

Hybrid light-matter quasiparticles called exciton-polaritons, formed by coupling photons with electrons in atomically thin semiconductors, enable strong light interactions sufficient for all-optical signal switching. This approach achieves switching at extremely low energy levels (~4 quadrillionths of a joule), potentially enhancing photonic chip efficiency and supporting direct optical processing and quantum computing functions.

Zhi Wang et al, Strongly Nonlinear Nanocavity Exciton Polaritons in Gate-Tunable Monolayer Semiconductors, Physical Review Letters (2026). DOI: 10.1103/gc15-qsvf

Comment by Dr. Krishna Kumari Challa yesterday

India’s DNA map uncovers millions of missing genetic variants A vast study reveals deep diversity, hidden disease risks and exposes the limits of Eurocentric medicine.

India’s DNA map reveals amazing diversity
India’s biggest gene-sequencing effort has shed new light on the diversity of the population, identifying nearly 130 million genetic variants, almost a third of which have not been reported previously. The GenomeIndia project analysed the whole genomes of almost 10,000 people, uncovering 44 million variants that weren’t already in global scientific databases. The study also revealed genetic risk factors in some populations, such as variants in genes that affect how the body processes certain drugs, variants linked to anaesthesia-related complications and extremely high levels of genetic homozygosity — when individuals inherit identical forms of a gene at a particular chromosome location from both parents. This can be a risk factor for recessive genetic diseases.

https://www.medrxiv.org/content/10.64898/2026.03.20.26348801v1

https://www.nature.com/articles/d44151-026-00082-0?utm_source=Live+...

Comment by Dr. Krishna Kumari Challa yesterday

Are microbes the future of pollution clean-up?
Synthetic biologists are engineering bacteria to feast on oil, plastic and toxic chemicals

Microbes eat pollution — if we let them
A growing community of synthetic biologists are using biotechnology-led solutions — mostly microorganisms containing DNA tailored for a specific function — to tackle pollution ranging from microplastics and industrial waste to soils laced with heavy metals or explosive residues. But the field is held back by concerns around releasing genetically modified organisms into the environment, and the fact that current incentives make polluting profitable while cleaning up costs money.

https://www.nature.com/articles/d41586-026-01420-z?utm_source=Live+...

Comment by Dr. Krishna Kumari Challa yesterday

Autoimmune gene provides viral protection

A variant of the gene PTPN22 linked to autoimmune diseases also appears to have a protective effect against viral infections. Researchers found that in mice, the presence of this variant kick-starts the activity of natural killer cells against a type of coronavirus. Removing natural killer cells from mice without the mutation had no effect on their ability to fight off the infection, which suggests these cells are not usually involved in the antiviral response. The findings could explain why this variant is relatively common in people, despite its link to diseases such as diabetes and lupus.

https://www.pnas.org/doi/10.1073/pnas.2519903123

• ‹ Previous
• 1
• 2
• 3
• …
• 1231
• Next ›
• Page